Who owns SALARIUS PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Salarius Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Salarius Pharmaceuticals stock

Who bought or sold SALARIUS PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Advisor Group Holdings 59.00 $32.998700 0% Sep 2025
 View chart
Morgan Stanley 7.00 $5.999700 100% Jun 2025
 View chart

Who sold out of Salarius Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Hrt Financial Jun 2025 32k $28k
UBS Group Jun 2025 18k $18k
Cubist Systematic Strategies Jun 2025 17k $15k
Geode Capital Management Jun 2025 16k $14k
Barclays Jun 2025 8.0k $7.0k
Tower Research Capital Jun 2025 3.7k $3.3k
Mount Yale Investment Advisors Jun 2025 61.00 $54.997600